ArticlePLoS pathogens2021

Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.

Emma T Crooks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.